Retinitis pigmentosa comprises a large and exceptionally heterogeneous grou
p of hereditary disorders of the retina, iis a result of an extensive inves
tigation around the world, primary genetic lesions have been described in m
any genes, Some of these genes encode enzymes that are involved in the sign
al transduction pathway. On the basis of in vitro functional assays and sta
ndard transgenic and knock-out experiments, it has been proposed that norma
l cell functions are disrupted because of an abnormal protein-folding and m
etabolic errors or structural defects in the membrane. This ultimately lead
s to a gene-mediated cell death known as apoptosis, Various gene transfer a
pproaches using mouse models further suggest that the degeneration can be r
escued to some extent. Although many questions remain to be answered, inves
tigations during the last 10 years have enormously increased our understand
ing of this exceptionally heterogeneous disorder and give hope for an effec
tive gene therapy and a possible cure.